Clinical Trial: Fecal Microbiota Transplant for Adult IBS-D, Montefiore Medical Center, New York, February 2016

February 28, 2016

Montefiore Medical Center, a major academic medical center in Bronx, New York (New York City) is currently recruiting men and women, ages 19-65 with physician-diagnosed, (Rome III criteria) irritable bowel syndrome with diarrhea (IBS-D) for a clinical trial to determine the possible  safety, feasibility and effectiveness of fecal microbiota transplantation for IBS-D. Potential volunteers must have moderate to severe symptoms that have not been managed effectively with existing treatments, not be currently pregnant or nursing, and not have been treated with antibiotics within 3 months of study enrollment. There are several additional medical exclusion criteria that may also apply, as listed on

The study involves randomized assignment to oral capsules of fecal microbiota from extensively screened donor stool or placebo taken for three days.  All volunteers will then cross over to the other group after 12 weeks and be followed for a total of 6 months.

If you are interested in volunteering to participate, please  contact Olga C. Aroniadis, MD,  at 718-920-4846,  or The study’s identifer is  NCT02329547.

This information is summarized from a posting by IFFGD and from the study listing at Montefiore Medical Center is one of three sites conducting this trial, with two others in New York City and Hamden, Connecticut given in the Clinical listing. Please address any questions or concerns directly to the research center.

We welcome researchers affiliated with academic, medical or pharmaceutical entities, or reputable organizations representing IBS or related or commonly overlapping conditions, to contact us directly with additional studies or surveys they wish to be considered for posting. A contact form is available on the main IBS Impact website.

IBS Impact makes these announcements available for general information, and encourages its members and site visitors to make their own individual, informed choices about their potential participation.  IBS Impact, as an entity, is not directly affiliated with any research sponsor or organization and receives no funding from any source for studies, surveys or links we feature on this blog, the main site or social media.

Updates to IBS for January-February 2016

February 4, 2016

IBS Impact has recently completed its latest update to many pages of the main website.

There have also been new details and resources added in the latest news column on the left of the home page,  IBS page, advocacy page, research pageIBS studies page, resources page, family and friends page and links page.  The most extensive modifications  for this round involve the IBS, advocacy, research, and family and friends pages.

Readers interested in the most recent news, events, clinical trial and advocacy opportunities, and articles between main site updates, may follow this blog or our Facebook or Twitter feeds (links found on the lower right sidebar of this blog). Regardless of one’s interest in IBS, whether personal or professional, most users should find useful and interesting material and links. The current site reflects resources in six countries which are among the top sources of hits to the site and this blog.

Because of the redesign and transfer of the site to new hosting in the fall of 2015, some links embedded in older posts on this blog or search engine results relating to IBS may result in error messages, but you should still reach the site itself. If so, please use the navigation links at the top of the site to reach the desired subpage.  No information that is still currently useful has been removed from the site, although in some cases, the location has changed. Only outdated details and occasional defunct links for which there is no replacement available at this time have been deleted.

Please feel free to check out the site here. Our goals with the website, blog and social media are to provide a varied range of current, scientifically accurate, reputable information and resources to people with IBS and their families and friends, and to encourage informed choices, proactive self-advocacy and public awareness of IBS, and the unmet medical or social needs many of us face as a result of IBS.

IBS Impact, as an entity, is not directly affiliated with any other organization, site or research sponsor and receives no funding for the information we post on the main website, this blog or our Twitter and Facebook pages. We do welcome constructive collaboration and value the many individuals, websites, organizations and clinical and research entities who continue to support, encourage and amplify our efforts in various ways to benefit the cause of IBS awareness and advocacy worldwide.

Comments, suggestions, corrections of outdated links, article submissions, and clinical trials or surveys by researchers affiliated with academic, medical, or pharmaceutical entities or reputable organizations representing IBS or commonly overlapping conditions in any country are all welcome and will be thoughtfully considered.  A new contact form can be found on the home page of the main site, or comments can be left on this blog.  Thank you to all of our readers and social media followers for your interest and participation.